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I N T R O D U C T I O N
Stromal  interaction  molecules  (STIMs)  STIM1  and 
STIM2 in the ER function as luminal Ca
2+ sensors that 
activate the calcium release–activated calcium (CRAC) 
channels CRACM1/2/3 (Orai1/2/3) in the plasma 
membrane after store depletion and give rise to the 
store-operated CRAC current (ICRAC) (Liou et al., 2005; 
Roos et al., 2005; Zhang et al., 2005; Feske et al., 2006; 
Spassova  et  al.,  2006;  Vig  et  al.,  2006b;  Lis  et  al.,   
2007; Parvez et al., 2008). Only the combined overex-
pression of sensor and channel proteins reconstitutes am-
plified CRAC currents (Mercer et al., 2006; Peinelt et al., 
2006; Soboloff et al., 2006; Zhang et al., 2006; Parvez   
et al., 2008). All three mammalian CRAC channel homo-
logues (CRACM1, CRACM2, and CRACM3) represent 
functional  store-operated  channels,  but  with  distinct 
characteristics (Lis et al., 2007). STIM1 functions as a 
Ca
2+ sensor in the ER (Liou et al., 2005; Roos et al., 
2005; Zhang et al., 2005), and store depletion causes it 
to redistribute from a diffuse localization throughout 
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the ER into puncta near the plasma membrane, fol-
lowed by CRAC channel migration to these areas (Luik 
et al., 2006). The distance between ER-resident STIM1 
puncta and the plasma membrane is in the range of   
10–25 nm (Wu et al., 2006), enabling a direct inter-
action as evident from fluorescence energy transfer sig-
nals from fused fluorophores (Barr et al., 2008; Muik   
et al., 2008; Navarro-Borelly et al., 2008) or coimmuno-
precipitation (Co-IP) (Vig et al., 2006a; Yeromin et al., 
2006; Yuan et al., 2009). It has also been suggested that 
CRACM1 is part of a larger molecular complex, as 
CRACM1 requires larger space between the two mem-
branes (11–14 nm) compared with STIM1 (4–6 nm) 
(Várnai et al., 2007). A recent study shows that STIM1–
CRACM1 interaction is sufficient to gate the CRAC 
channel into the open state in the absence of other pro-
teins of the CRACM1 channel complex (Zhou et al., 
2010). For the cytosolic part of STIM1, a direct inter-
action has been suggested by at least three independent 
studies that identified a minimal region in STIM1 that is 
needed for coupling to and activation of CRACM1. When 
overexpressed, these soluble fragments of STIM1, termed 
CRAC-activating  domain  (CAD)  (Park  et  al.,  2009), 
STIM1  Orai-activating  region  (Yuan  et  al.,  2009),  or 
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Store-operated Ca
2+ entry is controlled by the interaction of stromal interaction molecules (STIMs) acting as endo-
plasmic reticulum ER Ca
2+ sensors with calcium release–activated calcium (CRAC) channels (CRACM1/2/3 or 
Orai1/2/3) in the plasma membrane. Here, we report structural requirements of STIM1-mediated activation of 
CRACM1 and CRACM3 using truncations, point mutations, and CRACM1/CRACM3 chimeras. In accordance with 
previous studies, truncating the N-terminal region of CRACM1 or CRACM3 revealed a 20–amino acid stretch close 
to the plasma membrane important for channel gating. Exchanging the N-terminal region of CRACM3 with that 
of CRACM1 (CRACM3-N(M1)) results in accelerated kinetics and enhanced current amplitudes. Conversely, trans-
planting the N-terminal region of CRACM3 into CRACM1 (CRACM1-N(M3)) leads to severely reduced store-oper-
ated currents. Highly conserved amino acids (K85 in CRACM1 and K60 in CRACM3) in the N-terminal region 
close to the first transmembrane domain are crucial for STIM1-dependent gating of CRAC channels. Single-point 
mutations of this residue (K85E and K60E) eliminate store-operated currents induced by inositol 1,4,5-trisphos-
phate and reduce store-independent gating by 2-aminoethoxydiphenyl borate. However, short fragments of these 
mutant channels are still able to communicate with the CRAC-activating domain of STIM1. Collectively, these find-
ings identify a single amino acid in the N terminus of CRAC channels as a critical element for store-operated gating 
of CRAC channels.
© 2010 Lis et al.  This article is distributed under the terms of an Attribution–Noncommer-
cial–Share Alike–No Mirror Sites license for the first six months after the publication date 
(see http://www.rupress.org/terms). After six months it is available under a Creative Com-
mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described 
at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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M AT E R I A L S   A N D   M E T H O D S
Molecular cloning, mutagenesis, and overexpression
The N-terminal deletion mutants of CRACM1, N35, N49, N66, 
and N87, and CRACM3, N41 and N62, were prepared by PCR 
method using appropriate primers. The chimeras CRACM1-N(M3) 
(M1N3) and CRACM3-N(M1) (M3N1) were obtained by replacing 
the N-terminal region of CRACM1 (1–87) with the N-terminal   
region of CRACM3 (1–64) and vice versa by using overlapping 
primers with introduced restriction sites and PCR method. Junc-
tion sites of all chimeras were chosen based on conserved amino 
acid residues to avoid missing, changed, or additional residues 
at the junction sites. Full-length human CRACM1 and CRACM3 
were subcloned as described previously (Lis et al., 2007). All PCR 
products  were  subcloned  into  HA-pCAGGSM2-IRES-GFP  vector 
for the expression in mammalian cells. CRACM1 (amino acids 
48–91) and CRACM3 (amino acids 23–66) constructs were gener-
ated by PCR with appropriate primers and cloned into pECFP-C1 
vector using XhoI and BamHI restriction sites. All point mutations 
were introduced using the QuikChange XL site-directed mutagen-
esis kit (Agilent Technologies), and PCR products and constructs 
were verified by sequencing. The FLAG-Myc-CAD construct was pro-
vided by R. Lewis (Stanford University, Stanford, CA).
For electrophysiological analysis, CRACM proteins were over-
expressed in HEK293 cells stably expressing STIM1 (Soboloff   
et al., 2006) or transiently expressed FLAG-Myc-CAD using lipo-
fectamine 2000 (Invitrogen), and the GFP-expressing cells were 
selected by fluorescence. Experiments were performed 24–72 h 
after transfection. Cells cotransfected with FLAG-Myc-CAD (Park 
et al., 2009) and CRACM constructs were cultured in low cal-
cium media (20 µM) to minimize the toxicity of constitutively   
active ICRAC.
Electrophysiology
Patch clamp experiments were performed in the tight-seal whole 
cell configuration at 21–25°C. High-resolution current recordings 
were acquired using an EPC-9 amplifier (HEKA). Voltage ramps 
of 50-ms duration spanning a range of 150 to +150 mV were de-
livered from a holding potential of 0 mV at a rate of 0.5 Hz over a 
period of 100–300 s. All voltages were corrected for a liquid junc-
tion potential of 10 mV. Currents were filtered at 2.9 kHz and digi-
tized at 100-µs intervals. Capacitive currents were determined and 
corrected before each voltage ramp. We assessed the low-resolu-
tion temporal development of currents by extracting the current 
amplitude at 80, +80, and +130 mV from individual ramp cur-
rent records. Where applicable, statistical errors of averaged data 
are given as means ± SEM, with n determinations. Standard   
external solutions were as follows (in mM): 120 NaCl, 2 MgCl2,   
10 CaCl2, 10 TEA-Cl, 10 HEPES, 10 glucose, pH 7.2 with NaOH, and 
300 mOsm. In the CAD experiments, the cells were kept in nomi-
nal calcium-free external solution, and the standard external solu-
tion containing 10 mM Ca
2+ was applied. In some experiments, 
2-aminoethoxydiphenyl borate (2-APB) was added to the standard 
external solution at a final concentration of 50 µM. Standard in-
ternal solutions were as follows (in mM): 120 Cs-glutamate, 20 Cs · 
BAPTA,  3  MgCl2,  10  HEPES,  0.02  inositol  1,4,5-trisphosphate 
(IP3), pH 7.2 with CsOH, and 300 mOsm. All chemicals were pur-
chased from Sigma-Aldrich.
Immunofluorescence staining and confocal microscopy
HEK293 cells stably expressing STIM1 were transfected with vari-
ous CRACM1 and CRACM3 constructs (see above). For staining, 
cells were fixed with ice-cold methanol for 20 min at 20°C. Un-
specific binding sites were blocked with 2% BSA in 1× PBS for 1 h 
at room temperature. Thereafter, cells were stained with an anti-
HA antibody (1:600 in blocking solution; rat -HA; Roche) for 1.5 h 
at  37°C  and  a  detecting  antibody  conjugated  with  Alexa  658 
Orai-activating  small  fragment  (Muik  et  al.,  2009),   
induce constitutive CRAC currents.
Within CRACM proteins, the C-terminal cytoplasmic 
coiled-coil region has been reported to play a critical 
role in the binding of STIM1, and single-point muta-
tions within this region disrupt STIM1 coupling (Muik 
et al., 2008; Navarro-Borelly et al., 2008; Frischauf et al., 
2009). However, the role of the N terminus of CRACM1 
in the STIM1/CRACM1 signaling machinery is less clear. 
Deletion of the entire N-terminal portion of CRACM1 
inhibits activation of CRAC, but not co-clustering of the 
mutant with STIM1 (Li et al., 2007). Furthermore, STIM1 
inefficiently activates a CRACM1 variant in which the 
majority of the N-terminal residues are deleted (1–73) 
(Li et al., 2007; Yuan et al., 2009), whereas the STIM1 
Orai-activating region and CAD domains are both capable 
of coupling to and activating this deletion variant (Park 
et al., 2009; Yuan et al., 2009). In addition, the highly con-
served region proximately to the first transmembrane 
domain (74–91) not only plays an important role in the 
binding of CAD and activating ICRAC (Park et al., 2009) 
but also in calcium-dependent inactivation via calmodu-
lin (CaM) binding (Mullins et al., 2009). Recently, this 
region has been implicated to interact with another pro-
tein that may be part of the CRACM-STIM coupling ma-
chinery, called CRAC regulator 2A (CRACR2A), as this 
Ca
2+-binding protein has been shown to regulate store-
operated Ca
2+ entry (SOCE) by interacting with both 
CRACM1 and STIM1, and possibly participating in the 
assembly and stabilization of the CRACM1–STIM1 inter-
action (Srikanth et al., 2010).
A significant problem in assessing CRAC channel mu-
tations is that channel opening is the final step of a 
complex series of events, and any defect in the cascade 
results in lack of channel opening. In particular, it re-
mains unknown whether any molecular manipulation 
that  disrupts  STIM1-mediated  CRAC  channel  activity 
does so because of the inability of STIM1 to interact 
with the channel or because the mutation prevents 
channel gating. The highly conserved region between 
amino acids 74 and 91 in the N-terminal region of the 
CRACM proteins is very important for CRAC channel 
activation and STIM1 binding. Because this region con-
tains positively charged amino acids, we wondered if 
they might play a role either in the communication be-
tween STIM1 and CRACM proteins or in gating of the 
channel. We assessed this question using site-directed 
mutagenesis and chimeric constructs of CRACM1 and 
its homologue CRACM3, and by taking advantage of re-
cent observations that CRACM3 channel function can 
be probed independently of store depletion and STIM1 
signaling (DeHaven et al., 2008; Peinelt et al., 2008; 
Schindl et al., 2008; Zhang et al., 2008). Our results sug-
gest that a single residue near the first transmembrane 
segment of CRAC channels might be a crucial element 
for CRAC channel function.  Lis et al. 675
were used as secondary antibodies according to the manufactur-
er’s instructions. Proteins were detected by using the ECL Plus 
Western Blotting Detection System (GE Healthcare).
Online supplemental material
Fig. S1 shows small but enhanced 2-APB currents in the over-
expression  of  CRACM1-N(M3)  and  CRACM1.  Fig.  S2  illustrates   
the  function  of  double  mutants  in  CRACM1,  CRACM3,  and 
CRACM3-N(M1). Fig. S3 summarizes the analysis of positively 
charged amino acid residues in the N-terminal region of CRACM1. 
Fig.  S4  indicates  that  CRACM1-K85E  and  CRACM3-K60E  re-
duce the store-operated current in co-overexpression with the 
CRACM-wt proteins but not as efficiently as the SCID mutation 
CRACM1-R91W. Figs. S1–S4 are available at http://www.jgp.org/ 
cgi/content/full/jgp.201010484/DC1.
R E S U LT S
N-terminal region truncations
To  investigate  the  role  of  the  N-terminal  region  of 
CRACM1 and CRACM3 in STIM1-mediated channel ac-
tivity, we constructed mutants in which the proximal end 
of the N-terminal region was sequentially deleted (refer 
to Materials and methods). Fig. 1 shows average current 
amplitudes of inward currents in stable STIM1-express-
ing HEK293 cells transiently overexpressing the various 
deletion  mutants.  With  increasing  N-terminal  region 
truncations up to amino acid residue 50 in CRACM1, 
the  kinetics  and  current  densities  of  inward  currents 
(1:1,200 in PBS; goat -rat; Invitrogen) for 40 min at 37°C and vi-
sualized via confocal microscopy (LSM510; Carl Zeiss, Inc.) using 
z-stack imaging and a Plan-Apochromat 63×/1.4 oil DIC objective 
with optical zoom of three. Stacks ranged between 1.5 and 2 µm, 
and the pinhole was kept constant at 274 µm. For excitation, a 
HeNe laser (70%) was used at 543-nm wavelength. Emission was 
collected with a 560-nm long-pass filter, and images were analyzed 
with LSM Image Browser Software (Carl Zeiss, Inc.). Quantifica-
tions of plasma membrane and cytosolic fluorescence levels were 
performed in individual cells by analyzing fluorescence integrals 
of a narrow band of the cells’ contour (cortical plasma membrane 
region, 4–8-pixels wide) and central cell area enclosed by the band. 
Fluorescence densities per unit area were obtained by dividing the 
cumulative fluorescence intensities by the respective areas.
Western blotting and Co-IP
HEK293 cells were transiently cotransfected with FLAG-Myc-CAD 
and CFP-CRACM constructs (as described above). 24 h after trans-
fection, cells were harvested in PBS and lysed in 0.5 ml of lysis buf-
fer (in mM): 150 NaCl, 20 Tris-HCl, 10% glycerol, 1% Triton, and 
protease inhibitor cocktail (Sigma-Aldrich). The lysates were spun 
down at 8,000 g for 10 min, and the supernatant was precipitated 
with anti-FLAG M2 agarose beads (Sigma-Aldrich) for 4 h at 4°C. 
The total protein amount was determined by Bradford assay, and 
50 µg of the lysates was loaded as a control. Beads were washed 
four times with lysis buffer, and complexes were released with SDS-
loading buffer. Lysates and immunoprecipitations were resolved 
by SDS-PAGE and analyzed using anti-GFP goat polyclonal anti-
body (Santa Cruz Biotechnology, Inc.) at a dilution of 1:1,000 or 
an anti-FLAG mouse monoclonal antibody at a dilution of 1:7,500 
(Sigma-Aldrich). Anti–mouse IgG (1:12,500; GE Healthcare) and 
anti–goat IgG (1:80,000) peroxidase conjugate (Sigma-Aldrich) 
Figure 1.  Effects of N-terminal region truncations in CRACM1 and CRACM3. Average CRAC current densities at 80 mV induced 
by 20 µM IP3 in stable STIM1-expressing HEK293 cells transiently overexpressing truncation mutants. (A) CRACM1-wt (black; n = 45), 
CRACM1-N35 (green; n = 6), CRACM1-N49 (orange; n = 5), CRACM1-N66 (red; n = 5), and CRACM1-N87 (blue; n = 6). (B) Mag-
nified plot of the initial 120-s data from C. (C) CRACM3-wt (black; n = 9), CRACM3-N41 (red; n = 7), and CRACM3-N62 (blue; n = 5).   
Bars indicate external application of 50 µM 2-APB. (D–F) Average I-V relationships of CRAC currents extracted from representative 
HEK293 cells shown in A–C obtained at 120 s (D and E) and 180 s (F). Data represent leak-subtracted current densities (pA/pF) evoked 
by 50-ms voltage ramps from 150 to +150 mV. Error bars indicate SEM.676 STIM1-mediated gating of CRACM channels
observations are in line with previous studies (Liao et al., 
2007; Takahashi et al., 2007; Muik et al., 2008).
We next analyzed the CRACM3 protein, which is also 
activated  in  a  store-operated  and  STIM1-dependent 
manner but can be activated and probed for channel 
function by 2-APB, which can gate the channel inde-
pendently of store depletion, even in the absence of 
STIM1 overexpression (DeHaven et al., 2008; Peinelt   
et al., 2008; Schindl et al., 2008; Zhang et al., 2008).   
We  generated  two  truncation  mutants,  CRACM3-N41   
and CRACM3-N62, which are equivalent mutants to 
CRACM1-N66  and  CRACM1-N87,  respectively.  We 
assessed the ability of both mutants to be activated via 
were essentially identical to those obtained from wild-
type (wt) CRACM1 (Fig. 1 A), and the I-V relationships 
were typical of CRAC currents (Fig. 1 D; currents were 
extracted at the end of the experiment at 120 s). Even 
the CRACM1-N66 mutant reached similar maximal 
currents as wt CRACM1, although the kinetics of activa-
tion was slower. However, the complete removal of the 
cytoplasmic N-terminal region (CRACM1-N87) re-
sulted in the complete loss of CRAC currents, demon-
strating  that  CRACM1  N-terminal  region  deletions 
remain functional up to amino acid residue 66 and sug-
gesting that 20 amino acids close to the plasma mem-
brane are important for CRAC channel activity. These 
Figure 2.  Subcellular localization of CRAC channel variants. Stable STIM1-expressing HEK293 cells were transfected with pCAGGSM2 
vectors of various constructs. Cells were stained with an anti-HA antibody and a detecting antibody conjugated with Alexa 658 and   
visualized via confocal microscopy (LSM510; Carl Zeiss, Inc.). Bars, 10 µm. Images show representative examples of at least 10 individual 
cells for each construct. (A) CRACM1-wt construct (left) and chimera of CRACM1 with the CRACM3 N-terminal region (right). Both 
proteins, including the chimera, are expressed in the plasma membrane. (B) CRACM3-wt construct (left) and chimera of CRACM3 with 
the CRACM1 N-terminal region (right). Both proteins are expressed in the plasma membrane, although the expression of the latter   
appears to be less. (C) CRACM1-N87 (left) and CRACM1-K85E (right). Both constructs are inserted into the plasma membrane.   
(D) CRACM3-N62 (left) has reduced plasma membrane expression, and the CRACM3-K60E construct (right) shows expression in the 
plasma membrane. (E) Fluorescence densities obtained from confocal images, as shown in A–C. Values represent the average fluores-
cent intensities normalized to the unit area of the cortical and intracellular regions of 8–15 cells each.  Lis et al. 677
STIM1-dependent  gating  of  CRACM1  and  CRACM3   
requires some 20 amino acids of their N-terminal re-
gions right next to the plasma membrane. In addition, 
it appears that these 20 residues may be important for 
proper targeting of CRACM3 to the plasma membrane.
Chimeras
We have previously reported differences in kinetics and 
amplitude of STIM1-dependent activation of CRACM1 
and CRACM3 (Peinelt et al., 2008). CRACM1 currents 
typically activate more rapidly and to higher amplitudes 
compared with CRACM3, and we hypothesized that this 
might reflect differences in CRACM/STIM1 coupling. 
We addressed this question through chimeric constructs 
in which we mutually exchanged N- and C-terminal re-
gions of both proteins and where the N-terminal region 
of CRACM1 (amino acids 1–87) was substituted with 
that of CRACM3 (amino acids 1–62) and vice versa. 
Data obtained from these chimeras are shown in Fig. 3. 
The N-terminal region of CRACM1 conferred a signifi-
cant increase in current amplitude and acceleration of 
activation  kinetics  on  CRACM3  channels  (Fig.  3  A), 
whereas the typical I-V relationships of currents re-
mained  unchanged.  The  CRACM3-N(M1)  chimera 
(M3N1) localized in the plasma membrane (Fig. 2,   
B and E) but was expressed at higher levels than the 
parent CRACM3 channel, which likely accounts for this 
chimera’s larger current amplitudes. The accelerated 
kinetics of activation of this chimera ( = 26.9 ± 4.3 s) 
was similar to that of CRACM1 ( = 24.7 ± 4.4 s) rather 
than CRACM3 ( = 66.2 ± 8.3 s), suggesting that the   
N-terminal region harbors crucial structural elements 
mediating STIM1-dependent activation of CRACM1 and 
CRACM3. Conversely, exchanging the N-terminal region 
of CRACM1 with that of CRACM3 (CRACM1-N(M3), 
short M1N3) did not reproduce the CRACM3 cur-
rent  behavior, but instead resulted in severely reduced 
store-operated currents of just 0.8 pA/pF (Fig. 3 A),   
despite normal expression levels and localization to   
the plasma membrane (Fig. 2, A and E). This current   
is 20-fold reduced compared with CRACM3-wt and 
just slightly larger than endogenous CRAC currents ob-
served  in  control  cells  stably  overexpressing  STIM1 
(0.5 pA/pF; see Fig. S1). These currents are unlikely 
STIM1 by IP3-induced store depletion (Fig. 1 B) as   
well  as  pharmacological  STIM1-independent  gating  by   
2-APB (Fig. 1 C). Similar to CRACM1, in CRACM3 the 
partial truncation of the N-terminal region up to amino 
acid residue 41 did not change IP3-mediated currents 
compared with wt CRACM3, whereas the full truncation 
mutant CRACM3-N62 resulted in complete loss of IP3-
dependent activation (Fig. 1, B and E). The current aris-
ing from the CRACM3-N41 truncation was even slightly 
larger (20 vs. 15 pA/pF; Fig. 1 B) compared with wt 
CRACM3 currents but showed the characteristic ICRAC  
I-V relationship (Fig. 1 E). Because CRACM3 can be ac-
tivated independently of STIM1, we tested the truncated 
mutations for 2-APB–activated CRAC currents (Fig. 1,   
C and F). The application of 2-APB induced similar cur-
rent amplitudes in the CRACM3-N41 construct as in 
the wt CRACM3 (Fig. 1 C) with similar I-V relationships 
(Fig.  1  F).  The  CRACM3-N62  construct,  however, 
showed an inward current of about 4 pA/pF at 80 mV 
and an outward current of about +11 pA/pF at +80 mV 
(Fig. 1, C and F). The reduced current amplitudes com-
pared with wt channels were likely a result of lower ex-
pression levels and fewer channels being incorporated 
into the plasma membrane, as evident from immuno-
fluorescence staining and confocal analysis (Fig. 2,   
B and E). Nevertheless, this demonstrates that this mu-
tant can in principle form functional channels that can 
be activated by 2-APB but remain refractory to store de-
pletion and STIM1-mediated gating.
The above results could be interpreted to mean that 
the N-terminal 20 amino acids proximal to the plasma 
membrane are involved in STIM1-mediated gating of 
CRACM1 and CRACM3, or that they are required for 
adequate transport, localization, and/or formation of 
functional channels. To resolve this question, we as-
sessed the subcellular distribution of the full CRACM1 
N-terminal region truncation (CRACM1-N87) and 
found that the protein was at least targeted properly 
and localized within the plasma membrane (Fig. 2,   
B  and  E).  Immunofluorescence  also  showed  that  al-
though the CRACM3-N41 construct efficiently translo-
cated to the plasma membrane (not depicted), the full 
truncation mutant (CRACM3-N62) largely remained 
intracellularly (Fig. 2, B and E). Thus, it appears that 
Figure 3.  Function of N terminus chimeras of 
CRACM1 and CRACM3. (A) Average CRAC cur-
rent densities at 80 mV induced by 20 µM IP3  
in  stable  STIM1-expressing  HEK293  cells  tran-
siently overexpressing CRACM1-wt (black; n = 43),   
CRACM3-wt  (red;  n  =  70),  CRACM1-N(M3) 
(green; n = 5), and CRACM3-N(M1) (blue; n = 5). 
Error bars indicate SEM. (B) Average I-V rela-
tionships of CRAC currents extracted from repre-
sentative HEK293 cells shown in A and obtained 
at 120 s. Data represent leak-subtracted current 
densities (pA/pF) evoked by 50-ms voltage ramps 
from 150 to +150 mV.678 STIM1-mediated gating of CRACM channels
We  then  proceeded  with  single-point  mutations  of 
these residues and analyzed CRACM1 mutants in which 
we changed alkaline residue K78 to acidic glutamate 
residue (E) (Fig. S3) and K85 to glutamine (Q) or ala-
nine (A) (Fig. 4). Mutation K78E in CRACM1 was able 
to produce sizeable IP3-induced inward currents of 17 
pA/pF, similar in magnitude to those of wt channels 
(Fig. S3, B and C). However, the K85E mutant of CRACM1 
essentially  abolished  IP3-induced  currents,  producing 
inward currents of just 0.2 pA/pF (Fig. 4, A and C), 
although this mutation did localize to the plasma mem-
brane (Fig. 2, C and E). Nevertheless, 2-APB still evoked 
significant channel activation as evident from the out-
ward currents in Fig. 4 B and the I-V curve in Fig. 4 D. 
The substitution of the alkaline amino residue (K) by 
alanine, a not particularly hydrophobic and nonpolar 
amino acid, yielded similarly small IP3-induced inward 
currents of around 0.5 pA/pF (Fig. 4, A and C). How-
ever, 2-APB enhanced the outward currents to 8 pA/pF 
(at +130 mV), indicating that this mutation was also 
present and properly assembled in the plasma mem-
brane and could be gated STIM1-independently. A more 
conservative mutation of this residue is K85 to gluta-
mine (Q), an amino acid with a polar side chain that 
differs from glutamate (E) only in that it contains an 
oxygen in place of the amino group. This point muta-
tion, K85Q, was less efficient in suppressing STIM1- 
induced CRAC currents, yielding 10 pA/pF or 50% of 
the inward current typically seen with wt CRACM1. This 
indicates that the K85 residue in CRACM1 is indeed in-
volved in tuning the STIM1-mediated gating process. 
Interestingly, the K85Q mutant, while yielding reduced 
to represent endogenous channels alone because the 
application  of  2-APB  to  STIM1  cells  overexpressing 
CRACM1-N(M3) produced significantly larger currents 
than in STIM1 control cells (Fig. S1). Collectively, these 
data  suggest  that  the  N-terminal  region  of  CRACM 
channels  determines  the  STIM1-mediated  kinetics   
of activation.
CRACM1-K85E and CRACM3-K60E mutants
The 20-residue stretch proximal to the plasma mem-
brane in the cytosolic portion of the N-terminal region 
of CRACM proteins is crucial for STIM1-dependent gat-
ing  of  CRACM1  (amino  acids  67–87)  and  CRACM3 
(amino acids 42–62) channels (Fig. 1). Sequence analy-
sis of that part of the protein identifies it as a conserved 
region of high homology among CRACM proteins that 
contains a putative CaM-binding motif. This stretch of 
amino acids is able to bind CaM in a Ca
2+-dependent 
manner and plays a role in Ca
2+-dependent inactivation 
(Mullins et al., 2009). Therefore, we first created a dou-
ble-point  mutation  construct  that  would  disrupt  the 
CaM-binding motif in CRACM1 and the CRACM3-N(M1) 
chimera to investigate the potential effects on STIM1-
mediated channel activation (Fig. S2). This double mu-
tation in CRACM1 (K78E-K85E) failed to activate large 
IP3-  (Fig.  S2,  A  and  C)  or  2-APB–induced  currents 
(Fig. S2, B and D). This indicates a loss of function ef-
fect that not only prevents STIM1-mediated activation 
but also abolishes STIM1-independent gating of the chan-
nel because HEK293 cells transfected with wt CRACM1 
still  yield  small  IP3-induced  currents  that  can  be  en-
hanced by 2-APB (Fig. S1).
Figure 4.  Functional role of CRACM1-K85   
mutation.  Average  CRAC  current  den-
sities  at  80  and  +  130  mV  induced  by 
20  µM  IP3  in  stable  STIM1-expressing 
HEK293  cells  transiently  overexpressing 
point mutations. Black bars indicate the 
application  of  an  external  solution  con-
taining 50 µM 2-APB. Error bars indicate 
SEM.  (A)  Magnified  plot  of  the  initial 
120-s  data  from  B.  (B)  CRACM1-K85E   
(red; n = 6), CRACM1-K85Q (blue; n = 11),   
CRACM1-K85A  (green;  n  =  10),  and 
CRACM1-wt (black; n = 4: from a total of 
n = 12, four cells with the smallest current 
densities [induced by IP3] were averaged 
to approximate the lower current density 
of CRACM1-K85Q). (C and D) Average I-V 
relationships of CRAC currents extracted 
from representative HEK293 cells shown 
in A and B and obtained at 120 s (C) and 
180 s (D), when current was fully activated 
by 2-APB. Data represent leak-subtracted 
current densities (pA/pF) evoked by 50-ms 
voltage ramps from 150 to +150 mV.  Lis et al. 679
(Fig. S2, A and C), which were not significantly differ-
ent from those recorded in wt HEK293 cells overex-
pressing STIM1 alone (Fig. S1) (Peinelt et al., 2006). 
Although 2-APB was able to activate these channels   
(Fig. S2, B and D), indicating store-independent and 
direct gating of the channel, the current amplitudes did 
not reach the levels typically seen with the CRACM3 wt 
channel  (DeHaven  et  al.,  2007;  Peinelt  et  al.,  2008; 
Schindl et al., 2008; Zhang et al., 2008). The singular 
K78E  mutation  introduced  into  the  CRACM1-based   
N-terminal  region  of  the  chimera  behaved  normally 
and produced large IP3-induced inward currents of   
IP3-induced inward current, actually produced larger   
2-APB–induced currents compared with the CRACM1 
wt channel (Fig. 4, B and D).
Therefore, we next asked whether this residue modi-
fied channel function above and beyond STIM1-medi-
ated gating and also affected store-independent gating. 
To assess this, we used the CRACM3-N(M1) chimera, 
which  confers  the  CRACM1  gating  phenotype  on 
CRACM3 (Figs. 3 A and 5 A) and can also be activated 
STIM1-independently by 2-APB (Fig. 5 B). The double 
mutation K78E-K85E in the CRACM3-N(M1) chimera 
produced reduced IP3-induced currents of 0.65 pA/pF 
Figure  5.  Functional  role  of  N-terminal 
amino acid mutation in CRACM3-N(M1) chi-
mera and CRACM3. Average CRAC current 
densities  at  80  and  +130  mV  induced  by   
20 µM IP3 in stable STIM1-expressing HEK293 
cells  transiently  overexpressing  point  mu-
tation  or  chimera.  Black  bars  indicate  the 
application of an external solution contain-
ing 50 µM 2-APB. Error bars indicate SEM.   
(A and C) Magnified plot of the initial 120-s   
data  from  B  and  D.  (B)  CRACM3-N(M1) 
(black; n = 6), CRACM3-N(M1)-K78E (blue;   
n  =  6),  and  CRACM3-N(M1)-K85E  (red;   
n = 6). (D) CRACM3-R52E (green; n = 8), 
CRACM3-R53E (blue; n = 8), CRACM3-K60E 
(red;  n  =  7),  and  CRACM3-K60Q  (orange; 
n  =  9).  (E–H)  Average  I-V  relationships  of 
CRAC currents extracted from representative 
HEK293 cells shown in A–D and obtained 
at 120 s (E and G) and at 180 s (F and H), 
when  current  was  activated  by  2-APB.  Data 
represent leak-subtracted current densities 
(pA/pF) evoked by 50-ms voltage ramps from 
150 to +150 mV.680 STIM1-mediated gating of CRACM channels
Because the N-terminal region close to the first trans-
membrane domain in CRACM1 and CRACM3 contains 
several basic amino acid residues (Fig. S3 A), we as-
sessed their relevance for STIM1-mediated channel ac-
tivation. The substitutions of arginine (R) at position   
77 and lysine (K) at position 87 to glutamic acid reduce 
the IP3-induced current to 4 and 8 pA/pF (Fig. S3,   
B and C) compared with CRACM1. However, the overex-
pression of other point mutations at positions 69 and 87 
in HEK293 cells stably expressing STIM1 resulted in nor-
mal current sizes comparable to the wt channel (Fig. S3, 
B and C). Collectively, these results suggest that the K85 
residue in CRACM1 and K60 in CRACM3 are critical 
amino acids required for functional store-operated and 
STIM1-dependent activation of CRAC channels.
To assess whether the K85E and K60E mutations can 
assemble into heteromeric channel complexes and to 
test  for  dominant-negative  phenotype,  we  co-overex-
pressed K85E and K60E with respective wt constructs. 
Fig. S4 (A–C) illustrates that the co-overexpression of 
K85E and K60E in equal amounts with the wt homo-
logues  reduced  IP3-mediated  currents  by  50%  to 
10.97 pA/pF of the wt CRACM1 current and 90% to 
0.79 pA/pF of CRACM3. These results suggest that 
K85E  and  K60E  mutants  indeed  form  heterometric 
complexes  with  wt  homologues.  We  also  investigated 
another crucial amino acid within the N terminus of 
CRACM1, the previously identified R91W mutant that 
results in a human severe combined immunodeficiency 
(SCID) phenotype (Feske et al., 2006), and cotrans-
fected it with CRACM1 wt protein into HEK-293 cells 
stably  expressing  STIM1.  As  illustrated  in  Fig.  S4  D, 
CRACM1-R91W prevented the activation of large CRAC 
currents and produced current amplitudes of just 1–3 
pA/pF (Fig. S4 E). This amounts to 10% of the nor-
mally observed current amplitudes observed with the wt 
channels in the absence of this mutant and results in a 
stronger suppression of channel activity than the K85E 
mutant, which results in 50% reduction. These data 
indicate that the R91W mutant can coassemble with the 
wt CRACM1 subunit (Fig. S4, D and E), exerting a dom-
inant-negative effect on CRAC current in such hetero-
meric channels.
CRACM1-K85E and CRACM3-K60E mutants disrupt CRAC 
current activation by CAD but not by its binding
A minimal cytosolic region of STIM1 has been shown to 
functionally activate CRAC currents (Muik et al., 2009; 
Park et al., 2009; Yuan et al., 2009). This highly con-
served  CAD  encompasses  a  putative  coiled-coiled  re-
gion and part of the ERM domain of STIM1. Park et al. 
(2009) also demonstrated that CAD binds directly to   
N and C termini of CRACM1/Orai1 and that the mem-
brane-proximal  region  of  the  CRACM1  N  terminus 
(amino acid residues 68–91) is required to activate the 
CRAC channel. Because the lysine residue we identified 
32 pA/pF at 80 mV, and these were further acti-
vated by 2-APB (Fig. 5, A and B). However, the K85E 
mutation in this chimera strongly suppressed STIM1-
mediated activation of CRAC currents, producing just 
1.7 pA/pF of inward current at 80 mV. Although 
strongly reduced compared with the unmutated chi-
mera, this amount of current was still above the levels 
of endogenous CRAC currents, suggesting that chan-
nels were expressed in the plasma membrane but func-
tionally impaired with respect to STIM1-dependent 
activation.  Store-independent  gating  by  2-APB  was 
clearly present, although smaller than with the K78E 
mutant, suggesting that this mutant may additionally 
have a STIM1-independent functional defect (Fig. 5,   
B and F).
Finally, we asked whether STIM1-mediated gating of 
CRACM3  involved  a  similar  structural  requirement   
as  that  observed  for  K85  in  CRACM1.  At  first  we 
tested whether the equivalent double-point mutation 
in CRACM3, CRACM3-R53E-K60E, was able to prevent 
IP3- and 2-APB–mediated currents like the CRACM1-
K78E-K85E did. Indeed, the STIM1-dependent activa-
tion was reduced to 0.4 pA/pF (Fig. S2, A and C), 
and the store-independent gating by 2-APB was also 
dramatically suppressed (Fig. S2, B and D). The equiv-
alent single-point mutation to K78E (CRACM1), R53E 
in CRACM3, produced 50% smaller IP3-induced cur-
rents (6 pA/pF; Fig. 5, C and G) than the CRACM3 
wt, and these were further activated by 2-APB applica-
tion (Fig. 5, D and H). Next, we mutated the residue 
K60 in CRACM3 to glutamic acid (E) and tested for 
IP3- and 2-APB–induced activation. Just like the equiva-
lent  K85E  mutant  in  CRACM1,  the  CRACM3-K60E   
mutant failed to produce store-operated currents (cur-
rent amplitude at 80 mV was 0.4 pA/pF), suggesting 
that CRACM3 also relies on this residue for STIM1- 
mediated gating. Interestingly, the 2-APB–induced cur-
rents were also strongly reduced compared with the 
large currents evoked in wt CRACM3 (Fig. 5, D and H). 
This reduced amplitude, however, may not necessarily 
have been caused by impaired channel function but 
likely resulted from less efficient trafficking, as immuno-
fluorescence  staining  indicated  that  this  mutant  is 
largely  retained  intracellularly  with  less  prominent 
plasma membrane staining (Fig. 2, D and E). The sub-
stitution with a more conservative mutation of this   
residue, K60 to glutamine (Q), was less efficient in   
suppressing CRAC currents, reducing the inward cur-
rent typically seen with wt CRACM3 by 75% to 3.5 
pA/pF (Fig. 5, C and G), which indicates that this resi-
due is also involved in tuning the STIM1-mediated   
gating process. Store-independent activation by 2-APB 
was also clearly present, although smaller than with   
the CRACM3 wt, suggesting that this mutant addition-
ally affects the STIM1-independent activation (Fig. 5,   
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2+, producing a CRAC-like inward current of 43 
pA/pF (Fig. 6 A) and an I-V relationship characteristic 
of ICRAC (Fig. 6 B). Similar to CRACM1, the CRACM3-wt 
construct was able to produce a small inward current in 
response to 10 mM Ca
2+ (3.6 pA/pF; Fig. 6 C) with an 
ICRAC-like I-V relationship (Fig. 6 D). The introduction 
of point mutant CRACM1-K85E completely abolished 
CAD-mediated gating of this construct (Fig. 6, A and B), 
in the N terminus of CRACM1 lies exactly in this region 
(K85E), we asked whether it is required for CAD-medi-
ated gating of CRAC currents. We obtained the FLAG-
myc-CAD construct (Park et al., 2009) and confirmed 
that its coexpression with wt CRACM1 resulted in con-
stitutive activation of CRAC currents (Muik et al., 2009; 
Park et al., 2009; Yuan et al., 2009) that were revealed 
when the cells were exposed to 10 mM of extracellular 
Figure  6.  Lysine  residue  point  mutations 
of short CRACM1 and CRACM3 N-terminal 
constructs bind to the CAD of STIM1 but sup-
press  current  activation.  (A)  HEK293  cells 
were transfected with the FLAG-myc-CAD and 
CRACM1 or CRACM1-K85E construct, respec-
tively (refer to Materials and methods). Nor-
malized  current  densities  of  CAD-mediated 
CRAC currents at 80 mV are plotted against 
time  of  the  experiment.  Cells  were  kept  in 
nominal Ca
2+-free solution, and the bar indi-
cates the application of external solution con-
taining 10 mM Ca
2+. In control experiments, 
the application of Ca
2+ produced an inward 
current, characteristic of ICRAC (black; n = 7). 
The K85E mutation completely abolished cur-
rent  activation  upon  Ca
2+  application  (red; 
n = 9). Data represent the average leak-sub-
tracted current densities (pA/pF) evoked by 
50-ms voltage ramps from 150 to +150 mV.   
Error bars indicate SEM. (B and D) Average I-V   
relationships of CRAC currents extracted at 
120  s  from  representative  cells  shown  in  A 
and C. (C) Cells were transfected with FLAG-
myc-CAD  and  CRACM3  or  CRACM3-K60E 
constructs, respectively, and the average nor-
malized current densities at 80 mV are plot-
ted against time of the experiment. Similar to 
CRACM1, CRACM3 gave rise to ICRAC when 
10 mM Ca
2+ was applied (black; n = 5), indi-
cated by the bar. Likewise, the K60E mutation 
in  CRACM3  completely  abolished  current 
activation  (red;  n  =  5).  Error  bars  indicate 
SEM. (E and F) Representative Co-IP analysis 
of HEK-293 cells transfected with FLAG-myc-
CAD construct and various short N-terminal 
constructs of CRACM1 (E) or CRACM3 (F), 
respectively.  Immunoblotting  of  the  corre-
sponding lysates is shown in the left row. Lines 
represent control experiments of cells trans-
fected with the CAD construct only (14 kD), 
no transfected HEK293 cells, and the short 
N-terminal construct of CRACM1 or CRACM3 
(32  kD)  alone  or  cotransfected  with  the 
CAD construct. Blots in the upper lane were 
immunoblotted with anti-GFP antibody, and 
those in the lower lane were immunoblotted 
with  anti-FLAG  antibody.  The  upper  right 
lane  shows  the  actual  Co-IP,  using  agarose 
beads coated with FLAG antibody. For both 
CRACM1 and CRACM3, all three N-terminal 
constructs  bound  to  CAD.  The  lower  right 
lane represents the immunoprecipitated frac-
tion  immunoblotted  with  anti-FLAG.  The   
arrow  indicates  the  band  representing  the 
light chain of the FLAG antibody.682 STIM1-mediated gating of CRACM channels
the N terminus (K85E and K60E, respectively). Both 
short-construct mutants (CFP-M1-N48-91-K85E and CFP-
M3-N23-66-K60E) are able to bind to the nominal CAD in 
STIM1, indicating that the binding of STIM1 might be 
functional and not impaired. However, the lack of consti-
tutively active CRAC currents in CAD-overexpressing 
cells indicates a defect in channel gating and/or stable 
channel assembly despite CAD binding. Additionally, 
the K60E mutation in CRACM3 (but not the K85E muta-
tion in CRACM1) may also experience impaired channel 
trafficking to the plasma membrane (Fig. 2, D and E) and 
may contribute to reduced 2-APB–induced currents.
D I S C U S S I O N
This study provides an additional and complementary 
assessment  of  the  structural  requirements  of  store- 
dependent  as  well  as  store-independent  activation  of 
CRACM1 and extends it to its close homologue CRACM3. 
Here, we confirm that the N-terminal region between 
amino acid residues 67 and 87 is crucial for the activa-
tion of CRAC channels via STIM1. Our main novel ob-
servations are (a) the same N-terminal region (amino 
acids 42–62) is also crucial for store-operated activation 
of CRACM3 channels; (b) chimeric constructs demon-
strate  that  the  efficacy  of  STIM1-mediated  gating  in 
terms of kinetics and magnitude depends on the N ter-
minus; (c) point mutations identify a single crucial ly-
sine residue in the N-terminal region of CRAC channels 
(K85 and K60 in CRACM1 and CRACM3, respectively) 
that participates in the gating of CRAC channels; (d) 
the  K60E  mutation  in  CRACM3  also  shows  reduced   
2-APB–induced currents; (e) additionally, the K60E   
mutation in CRACM3 also seems to impair channel traf-
ficking to the plasma membrane and may contribute to 
the strong suppression of STIM1- and 2-APB–induced 
currents; and (f) a short stretch of the CRAC N termi-
nus (amino acids 48–91 and 23–66) hosting the lysine 
residues K85E and K60E, respectively, can still bind to 
the CAD region of STIM1 in an artificial binding assay, 
and so does the N terminus of CRAC with SCID muta-
tions R91W and R66W, respectively.
Although the available data indicate a critical role of 
the C-terminal region in interacting with STIM1, the 
functional role of the N-terminal region is less clear. 
Previous studies have demonstrated that the cytoplas-
mic  C-terminal  region  is  required  for  its  interaction 
with STIM1, and the C-terminal region of STIM1 is able 
to bind to the C-terminal region of CRACM1 but not to 
the N terminus (Muik et al., 2008). Also, deletion of the 
C-terminal region or an L273S mutation in CRACM1 
completely suppresses STIM1 binding and activation of 
ICRAC (Li et al., 2007; Muik et al., 2008). On the other 
hand, Takahashi et al. (2007) proposed that the N-ter-
minal region plays an essential role in STIM1-mediated 
SOCE. The chimeric constructs in which we exchanged 
and so did the CRACM3-K60E mutant (Fig. 6, C and D). 
Thus, altering this particular lysine residue in the N-ter-
minal region of both CRACM1 and CRACM3 channels 
creates a mutant that can no longer be gated by CAD.
Because the above mutants abolished the CAD-medi-
ated gating of CRAC currents, we asked whether this 
residue is part of a CAD-binding site at the N terminus 
of CRAC channels. To address this question, we de-
signed a short CRACM1 wt (CFP-M1-N48-91) construct 
based on the previously identified membrane-proximal 
region of the CRACM1 N-terminal domain (amino ac-
ids 48–91) (Park et al., 2009). In addition, we designed 
a corresponding 44–amino acid construct (amino acids 
23–66) of the wt CRACM3 protein (CFP-M3-N23-66).   
To test if the lysine point mutations interfere with CAD 
binding to CRACM1 and CRACM3, we performed site-
directed mutagenesis on these constructs and assessed 
Co-IP of FLAG-myc-CAD and the various short CRACM1 
and CRACM3 constructs, respectively. As demonstrated 
previously (Park et al., 2009), the short N-terminal CFP-
M1-N48-91 construct (amino acid residues 48–91) can di-
rectly bind to the CAD construct (Fig. 6 E). We used this 
short construct to avoid binding to the C-terminal re-
gion of the full-length CRACM1 protein. The K85 mu-
tant (CFP-M1-N48-91-K85E) retained the ability to bind 
to CAD, although possibly a little weaker than the wt 
construct, as seen in Fig. 6 E. Although we cannot rule 
out that a slightly weaker binding could be sufficient to 
disrupt STIM1’s ability to gate CRACM1, the binding 
activity that remains with K85E would indicate that the 
lysine residue does not fully account for the interaction 
of CAD to the N terminus of CRACM1. Because the   
mutation of the arginine amino acid residue 91, which 
gives rise to a SCID phenotype in humans (Feske et al., 
2006), lies in the same membrane-proximal region that 
has been shown to be relevant for CRAC channel gat-
ing, we also tested whether a CFP-M1-N48-91-R91W con-
struct could bind to CAD. Our Co-IP, using the CAD of 
STIM1 (Fig. 6 E), confirmed earlier results by Derler   
et al. (2009) that the arginine residue is not relevant for 
the binding of STIM1. Finally, we tested for the binding 
of CAD to the corresponding short CRACM3 constructs 
(Fig. 6 F). The binding assay of CAD to CFP-M3-N23-66 
yielded similar results, as the short CRACM1 wt con-
struct showed a clear Co-IP band. In addition, the K60E 
mutant (CFP-M3-N23-66-K60E) as well as the CFP-M3-N23-66-
R66W mutation (corresponding to the CRACM1-R91W 
SCID mutant) also exhibited CAD binding (Fig. 6 F). 
Thus, although these mutations in the short CRACM1 
and CRACM3 constructs do not significantly interfere 
with the binding of CAD, they represent crucial resi-
dues  for  the  STIM1-dependent  gating  of  the  CRAC 
channel downstream of STIM1 binding.
Collectively, our results indicate that the opening of 
CRACM1 and CRACM3 channels is completely abolished 
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N-terminal fragments of the K85E mutant in CRACM1 
and K60E (CRACM3), respectively, are still able to bind 
to the minimal binding domain of STIM1 (CAD) (Fig. 6, 
E and F), but the gating or stable assembly of the chan-
nel is impaired. This position K85 has been suggested to 
be important for the CRACM1 binding to the CRAC 
regulator  (CRACR2A)  and  thus  might  destabilize   
the interaction of CRACM and STIM1 (Srikanth et al., 
2010). Therefore, it is possible that STIM1 is still able to 
bind to the N-terminal region of CRACM1 or CRACM3; 
however, CRACR2A is not, possibly affecting SOCE.   
It should be noted, however, that the role of CRACR2A 
in SOCE requires further investigation because this pro-
tein is not required for STIM1 and CRAC channel inter-
action  in  reconstituted  systems  where  the  protein  is 
likely absent (Zhou et al., 2010). In any event, our ob-
servations suggest that a simple binding of STIM1 to the 
C- and/or N-terminal region of CRACM1 or CRACM3 
may not by itself be sufficient to trigger channel gating 
into the open state. Instead, at least one further confor-
mational step appears to be required to open the chan-
nel pore, and the lysine residues within the N terminus 
identified here might be critical for this step.
Exchanging the positively charged and polar lysine 
residue  for  an  uncharged  and  nonpolar  amino  acid 
such as alanine (CRACM1-K85A) completely abolished 
IP3-induced currents and strongly decreased store-inde-
pendent responses with 2-APB. When switching to the 
uncharged but polar amino acid residue glutamine 
(CRACM1-K85Q),  the  IP3-induced  currents  could  be 
restored, indicating that glutamine may create a suffi-
ciently polar environment to support STIM1-mediated 
activation. Interestingly, however, this mutant exhibited 
enhanced outwardly rectifying currents when exposed 
to 2-APB compared with CRACM1 wt channels (Peinelt 
et al., 2008). The reason for this might be a better acces-
sibility of the 2-APB compound to the channel, resulting 
in altered ion selectivity (Peinelt et al., 2008; Schindl   
et al., 2008). Alternatively, during 2-APB application, the 
N terminus may contribute to inward rectification of CRAC 
currents by impeding outward movement of monovalent 
cations, with mutations in this region being less effec-
tive in doing so and enabling limited outward currents 
in conjunction with changes in pore selectivity induced 
by 2-APB. Introducing a negative charge by mutating the 
lysine  residue  into  the  polar  but  negatively  charged 
amino acid residue glutamic acid (CRACM1-K85E or 
CRACM3-K60E)  again  resulted  in  complete  disrup-
tion of the IP3-mediated CRAC currents. In this case, 
the presence of a negative charge strongly impaired 
the gating function of the CRAC channel and almost 
completely abolished the store-independent response 
to 2-APB (Fig. 4). At the same time, position 85 in the 
N-terminal region close to the first transmembrane   
domain appeared to be particularly important for chan-
nel gating because the equivalent mutations of other 
N termini of both channels with each other support the 
notion that the N-terminal region of CRACM1 indeed may 
also be involved in STIM1-mediated gating because it can 
confer the gating phenotype of CRACM1 onto CRACM3 
in terms of current kinetics and magnitude (Fig. 3).
Complete truncation of the N-terminal region up to 
residue 87 of CRACM1 results in failure of channel open-
ing  (Fig.  1).  These  constructs  localize  to  the  plasma 
membrane (Fig. 2) and can interact with STIM1 (Liao   
et al., 2007; Muik et al., 2008). Our data further iden-
tify a single amino acid, K85 in CRACM1 and K60 in 
CRACM3, as crucial residues for store-operated current 
activation. Although these residues are located within a 
putative CaM-binding domain, it seems unlikely that they 
mediate their effects by disrupting CaM binding, because 
structural modeling would require at least a double mu-
tation to do so; the single lysine mutations still retain the 
highest possible score for a functional CaM-binding mo-
tif. In addition, although CaM binds to CRACM1 in a 
Ca
2+-dependent manner (68–91), it is not thought to me-
diate CRAC channel activation, but rather plays a role in 
Ca
2+-dependent inactivation (Mullins et al., 2009) and 
may also inhibit STIM2-dependent activation of CRACM1 
(Parvez et al., 2008). Finally, it would appear that CRAC 
channels  and  STIM  proteins  are  entirely  sufficient  to 
produce  channel  openings  in  a  reconstituted  system 
where CaM is likely absent (Zhou et al., 2010).
The dramatic reduction in store-operated activation 
of CRAC channels with mutations in the critical N-ter-
minal lysine residue suggests that this residue is involved 
in conformational changes that lead to channel open-
ing, despite the ability of STIM1 to bind. An alternative 
or contributing factor might be that these residues are 
required for the assembly or stability of CRAC channel 
complexes. Recently, Srikanth et al. (2010) identified a 
CRAC regulator protein (CRACR2A) that is thought to 
be essential for the assembly and/or stability of the 
CRACM-STIM  clusters  and  whose  binding  sites  on 
CRACM1 and STIM1 partially overlap with those of CaM. 
They demonstrated that a double mutation on CRACM1, 
K85A/K87A, completely disrupted CRACR2A binding. 
Furthermore, a minimal region of the STIM1 protein 
has been identified that is needed for coupling to and 
inducing constitutive activity of CRAC channels (Muik 
et al., 2009; Park et al., 2009; Yuan et al., 2009). C and N 
termini of CRACM1 are both necessary to activate ICRAC, 
but the first 73 amino acid residues in CRACM1 protein 
are not absolutely required for activation (Li et al., 2007; 
Park et al., 2009). However, the additional deletion of 
the  amino  acid  residues  73–84  from  CRACM1  elimi-
nated CAD binding to the N-terminal region and re-
sulted in suppressed Ca
2+ influx induced by CAD (Park 
et al., 2009). Nevertheless, the reported interaction of 
CAD with both the C and N termini of CRACM1 (Park 
et al., 2009) suggests an essential regulatory role in the 
CRACM1 channel gating. In the present study, the short 684 STIM1-mediated gating of CRACM channels
residues because the mutation of a positive amino acid 
residue to a negatively charged residue K85E mutant 
completely  disrupts  STIM1-dependent  current  activa-
tion (0.2 pA/pF), whereas the corresponding R91E 
mutation does not affect CRAC current activation (6–8 
pA/pF; Derler et al., 2009). The mutation to a neutral 
amino  acid,  K85A,  also  resulted  in  a  nonfunctional 
channel (0.37 pA/pF), whereas the corresponding 
R91G does not disrupt current activation (6–8 pA/pF; 
Derler et al., 2009). Thus, on a molecular basis, the two 
residues are clearly distinct from each other.
Similar to the CRACM3-R66W (SCID), the CRACM3-
K60E  mutation  disrupts  STIM1-dependent  current 
activation, but unlike R66W, it still can be activated   
in a store-independent manner by 2-APB to a certain 
amount. With respect to the CRACM1-R91W mutation, 
our results confirm that overexpression of this mutant 
alone results in almost complete suppression of CRAC 
currents below control levels and therefore may act as a 
dominant-negative  subunit  for  endogenous  channels 
(Fig. S4, A and B). The co-overexpression experiments 
further demonstrate that the CRACM1-R91W mutant 
can suppress CRACM1 channel subunits, presumably 
because they can form heteromultimers (Lis et al., 
2007). These data (Fig. S4) are at odds with a recent re-
port  that  showed  relatively  normal  CRACM1  current 
amplitudes when coexpressing the mutant and wt chan-
nels, with just a slower kinetics after passive store deple-
tion (Muik et al., 2008). A possible explanation for this 
discrepancy might be differences in the efficacy of mu-
tant subunit expression in the two studies. Analysis of 
the amount of reduction suggests that a single R91W 
subunit is enough to essentially block channel function. 
Assuming equal expression levels and unbiased assem-
bly into tetramers, there are 16 possible assemblies.   
Under  these  conditions,  homomeric  wt  CRACM1  as-
semblies remaining fully functional would then be able 
to generate 6.25% of the wt current, namely 1.75 pA/pF 
of 28 pA/pF in controls, which is almost exactly the 
amount of current we observed: 1.76 pA/pF. Based on 
the above considerations and with the caveat of neces-
sary assumptions in the calculations, we propose that 
incorporation of just one R91W subunit into the CRAC 
channel complex may be sufficient to essentially block 
its current flow. Hence, the effect of this mutant could 
result from a dominant-negative effect if it formed het-
eromeric channels with endogenous channel subunits, 
which  has  been  demonstrated  to  be  the  case  for  wt 
CRACM proteins (Vig et al., 2006a; Lis et al., 2007).
So far, four single amino acids in CRACM1 have been 
identified as crucial for channel function, and point 
mutations in these residues result in complete loss of 
function. (1) E106Q is a pore mutant that disrupts ion 
conduction  and  acts  as  a  dominant-negative  subunit 
(Prakriya and Lewis, 2006; Vig et al., 2006a; Yeromin   
et al., 2006). (2) R91W is a mutation that disrupts SOCE 
positively charged amino acid residues at positions 69, 
77, 78, 83, and 87 (Fig. S3) had no such strong inhibi-
tory effect and were still able to elicit IP3-mediated cur-
rent activation.
N terminus truncations CRACM1-87 and the corre-
sponding  CRACM3-62  truncations  (resulting  in  the 
deletion of crucial lysine residues K85 and K60, respec-
tively) strongly suppress both channels but appear to   
affect CRACM1 and CRACM3 differentially in terms of 
trafficking, because CRACM1 localization appears nor-
mal, whereas CRACM3 is partly retained in intracellular 
compartments (Fig. 2). Although the trafficking defect 
reduces the number of CRACM3 channels in the plasma 
membrane, those channels remain functional, because 
2-APB can gate the channels that do transfer to the 
plasma membrane. Previous publications dealing with 
CRACM1/STIM1 binding and regulation have not con-
sidered the two distinct gating modes of CRAC channels: 
a store-operated (STIM1-dependent) and non–store-oper-
ated gating by 2-APB (STIM1-independent) (DeHaven   
et al., 2007; Peinelt et al., 2008; Schindl et al., 2008; 
Zhang et al., 2008). The results in the present study now 
demonstrate that the CRACM3 N-terminal region is es-
sential for store-operated STIM1-dependent gating but 
not essential for non–store-operated gating of CRACM3 
channels by 2-APB. This is not entirely surprising, be-
cause the STIM1-dependent gating requires binding of 
STIM1 to the C-terminal region and subsequent confor-
mational changes of the N-terminal region. In general, 
we found that CRACM3 trafficking may rely more heav-
ily on the structural integrity of its N terminus because 
truncating or mutating this segment results in improper 
targeting to the plasma membrane (see Fig. 2).
Detailed analysis of the current densities supports the 
notion of a strong inhibitory effect of the CRACM3 
point mutation, suggesting that a single K60E subunit is 
enough to strongly block the channel function. Assum-
ing equal expression levels and unbiased assembly into 
tetramers, there are 16 possible assemblies. Under these 
conditions, homomeric wt CRACM3 assemblies remain-
ing  fully  functional  would  then  be  able  to  generate 
6.25% of wt current (or 0.79 pA/pF of 12.75 pA/pF 
in controls). Experimentally, the amount of current we 
observe is 1.37 pA/pF, suggesting that the insertion of 
a single mutant subunit into a tetrameric channel ap-
pears to be sufficient to reduce channel function almost 
completely. In the case of the CRACM1 mutant K85E, 
we see a 50% inhibition of current compared with wt 
(or 10.97 pA/pF of 23.4 pA/pF in controls), and 
this would indicate that at least two subunits are neces-
sary to account for the inhibitory effect we observe.
Because a mutation in the K85/K60 residue disrupts 
store-operated calcium influx, we would assume that in 
humans the K85E mutation might yield a similar SCID 
phenotype  as  demonstrated  for  the  R91W  mutation. 
However, there are differences in the behavior of these   Lis et al. 685
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in T cells and underlies the SCID pathology in human 
patients (Feske et al., 2006). The protein expresses in 
the plasma membrane, but it cannot support ion cur-
rents. The increased hydrophobicity at the interface of 
the  N  terminus–membrane  has  been  claimed  as  the 
main  cause  for  the  nonfunctional  channel  (Derler   
et  al.,  2009).  (3)  L273S  (Muik  et  al.,  2008)  and  (4) 
L276D (Navarro-Borelly et al., 2008) are C-terminal– 
region mutants that have been proposed to be crucial 
for STIM1-dependent activation of CRACM1 because 
they localize to the plasma membrane but fail to inter-
act with STIM1. The new K85 residue does not appear 
to be a part of the selectivity filter because the K85Q 
mutation develops IP3-induced currents with the distinc-
tive I-V relationship of ICRAC (Fig. 4 C), whereas the K85E 
mutant appears to be a loss-of-function mutation. Because 
the same mutation in the chimera (CRACM3-N(M1)-
K85E) remains unavailable for STIM1-dependent gat-
ing  but  can  still  be  activated  in  a  store-independent 
manner with 2-APB (Fig. 5, B and F), we propose that 
this residue is essential for the gating and/or stable as-
sembly of CRAC channels.
CRAC channel opening is the final step of a complex 
series of events (Muik et al., 2009; Park et al., 2009; Yuan 
et al., 2009), and any defect in the cascade results in 
lack of channel opening. The initial step in STIM1/
CRAC communication seems to be preserved, as judged 
from the Co-IP experiments that suggest intact binding 
properties of mutants that render CRAC channels si-
lent. Nevertheless, these experiments might not repre-
sent the actual mechanism of interaction of full-length 
CRACM and STIM1 proteins because only the minimal 
fractions are used for our binding studies. However, the 
lack of channel opening supports the concept of the 
K85 and K60 residues in CRACM1 and CRACM3, re-
spectively, as critical for the gating of the channel. Fi-
nally, our results support the hypothesis that the opening 
of CRAC channels may entail a sequential process that 
involves the binding of STIM1 to the coiled-coil region 
within the C-terminal region, which then causes a bridg-
ing toward the N-terminal region, resulting in a con-
formational change in CRAC channels to accomplish 
channel gating (Park et al., 2009). In light of recent 
work that proposes a tetrameric assembly of CRAC chan-
nel subunits interacting with dimeric STIM1 (Li et al., 
2008; Mignen et al., 2008), and the direct binding of 
CAD to N and C termini of CRACM1 (Park et al., 2009), 
we further propose that the basic amino acid lysine (K) 
at the position 85 in CRACM1 (and K60 in CRACM3) is 
indispensable for the conformational changes to drive 
the opening of the CRAC channels and Ca
2+ entry.
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